Coca-Cola European Partners PLC is expecting 2019 to be a year of positive growth in sales and profit for the company.
The bottler of Coca-Cola products has predicted low single-digit revenue growth (excluding impact from currency fluctuations or incremental soft drink taxes), and 6%-7% increase in comparable operating profit for 2019. The company’s forecast for earnings-per-share growth is 10%-11%.
The company also reported its fourth quarter performance. Its revenue in the quarter increased + 5% year-over-year to touch 2.8 billion euros – as prices rise more than offset decline in volume. Volume dropped -2.5%, while revenue per case rose +6%. Comparable earnings per share came in at 54 euro cents.
Coca-Cola European Partners will be spending upto 1 billion euros in stock buybacks this year.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CCEP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 21 of 33 cases where CCEP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 64%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CCEP's RSI Oscillator exited the oversold zone, 10 of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 27 of 51 cases where CCEP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for CCEP just turned positive on September 29, 2026. Looking at past instances where CCEP's MACD turned positive, the stock continued to rise in 24 of 48 cases over the following month. The odds of a continued upward trend are 50%.
Following a +0.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCEP advanced for three days, in 191 of 353 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCEP as a result. In 43 of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 43%.
CCEP moved below its 50-day moving average on September 04, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CCEP crossed bearishly below the 50-day moving average on September 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCEP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 36%.
The Aroon Indicator for CCEP entered a downward trend on October 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.803) is normal, around the industry mean (6.793). P/E Ratio (20.364) is within average values for comparable stocks, (43.051). Projected Growth (PEG Ratio) (2.715) is also within normal values, averaging (3.732). Dividend Yield (0.023) settles around the average of (0.014) among similar stocks. P/S Ratio (1.873) is also within normal values, averaging (2.785).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. CCEP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a bottling company with interests in marketing, production and distribution of Coca-Cola products
Industry BeveragesNonAlcoholic